PURPOSE In 2023 the American Urological Association (AUA) requested an Update Literature Review (ULR) to incorporate new evidence generated since the 2019 publication of this Guideline. The resulting 2024 Guideline Amendment addresses updated recommendations to provide guidance for the care of patients with incontinence after prostate treatment (IPT). MATERIALS AND METHODS In 2023, the IPT Guideline was updated through the AUA amendment process in which newly published literature is reviewed and integrated into previously published guidelines. There were 82 studies of interest initially identified in preliminary abstract review. Following full-text review, 17 studies met inclusion criteria and ultimately informed the statements of interest. RESULTS The Panel developed evidence- and consensus-based statements based on an updated review to provide guidance for the care of patients who experience IPT. These updates are detailed herein. CONCLUSIONS As prostate treatments are refined, a decreasing incidence of incontinence is anticipated. This Guideline will require further review as the diagnostic and treatment options for patients with IPT continue to evolve.

中文翻译：

---

前列腺治疗后失禁更新：AUA/GURS/SUFU 指南 (2024)。


目的 2023 年，美国泌尿外科协会 (AUA) 要求进行更新文献综述 (ULR)，以纳入自 2019 年发布本指南以来产生的新证据。由此产生的 2024 年指南修正案提出了更新的建议，为前列腺治疗 (IPT) 后失禁患者的护理提供指导。材料和方法 2023 年，IPT 指南通过 AUA 修订过程进行了更新，其中对新发表的文献进行了审查并将其整合到之前发布的指南中。初步摘要审查初步确定了 82 项感兴趣的研究。经过全文审查，17 项研究符合纳入标准，并最终为兴趣陈述提供了信息。结果 专家组根据更新的审查制定了基于证据和共识的声明，为经历 IPT 的患者的护理提供指导。这些更新详见此处。结论 随着前列腺治疗的完善，失禁的发生率预计会降低。随着 IPT 患者的诊断和治疗方案不断发展，本指南需要进一步审查。